For Providers

How to Refer a Patient

Referrals are welcome from psychiatric providers, therapists, primary care providers, and other medical professionals.

Please fax referrals to: 423-523-0848 

We aim to respond within 3 business days.

Spravato® Indications & Contraindications

Spravato® (esketamine) is FDA-approved for adults with treatment-resistant depression. Indications include:

• Diagnosis of Major Depressive Disorder (MDD)

• Inadequate response to at least two different antidepressants

• Ability to safely attend in-office monitoring appointments twice per week initially

Spravato may not be appropriate for patients with:

• Aneurysmal vascular disease

• History of intracerebral hemorrhage

• Unmanaged substance use disorder

• Active psychosis

• Unstable cardiovascular conditions

If you’re unsure, feel free to consult with us - we’re happy to collaborate on clinical appropriateness.

Insurance & Payment

NeuroBloom offers transparent self-pay rates and accepts most major insurance plans.